JAPhA Practice Innovations最新文献

{"title":"Development of a framework for implementation of pharmacist-led dermatology clinics","authors":"Ruki Wijesinghe","doi":"10.1016/j.japhpi.2025.100038","DOIUrl":"10.1016/j.japhpi.2025.100038","url":null,"abstract":"<div><h3>Background</h3><div>The current landscape of pharmacy practice presents a notable gap for pharmacists specializing in dermatology who seek to establish clinics and specialized services. Unlike other specialized fields, there is a lack of specialized training or specific Board of Pharmacy Specialties certification tailored to dermatology.</div></div><div><h3>Objective</h3><div>This study aimed to explore how entrustable professional activities (EPAs) can revolutionize workplace-based training, addressing specialized needs to evolve the roles of dermatology clinical pharmacists.</div></div><div><h3>Methods</h3><div>A multidisciplinary team of dermatologists, clinical pharmacists, and scholars was formed to create core EPAs and competencies, ensuring high-quality EPA construction through consensus. To align pharmacists’ roles with dermatologists in specialized settings, preliminary EPAs were drafted with a deep understanding of dermatologists’ workflows and pharmacists’ scope of practice.</div></div><div><h3>Results</h3><div>Six core workplace-based EPAs were identified ranging from patient assessment to monitoring. These EPAs, detailed with specific tasks and assessment tools, allowed pharmacists to specialize and efficiently conduct dermatology pharmacist clinics, benefiting patients and the institution. This model’s success led to the sustained operation of dermatology pharmacist clinics, expanding pharmacists’ roles in dermatology subspecialties.</div></div><div><h3>Conclusion</h3><div>A small-scale EPA framework to train clinical pharmacists for independent roles in dermatology clinics was successfully implemented, demonstrating EPAs’ potential to broaden pharmacists’ scope in such settings. This approach provides a model for integrating clinical pharmacists into collaborative teams and can be adapted for training of pharmacists in other specialized settings.</div></div>","PeriodicalId":100737,"journal":{"name":"JAPhA Practice Innovations","volume":"2 2","pages":"Article 100038"},"PeriodicalIF":0.0,"publicationDate":"2025-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143704192","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Pharmacist confidence, comfort, and experience screening for and addressing social risks","authors":"Martha Schanandore,&nbsp;Courtney E. Gamston,&nbsp;Lindsey Hohmann,&nbsp;Lena McDowell,&nbsp;Greg Peden,&nbsp;Kimberly Braxton Lloyd","doi":"10.1016/j.japhpi.2025.100033","DOIUrl":"10.1016/j.japhpi.2025.100033","url":null,"abstract":"<div><h3>Background</h3><div>Social determinants of health (SDoH) account for 50%-60% of health outcomes. Pharmacists are uniquely positioned to screen for adverse SDoH (social risks), and address social needs, conditions an individual seeks assistance with immediately. However, previous research has demonstrated that pharmacists lack confidence and experience performing this screening.</div></div><div><h3>Objective</h3><div>This study aimed to assess pharmacist self-perceived knowledge, comfort, and experience screening for SDoH and confidence addressing social needs.</div></div><div><h3>Methods</h3><div>Registered Alabama pharmacists were invited via e-mail to complete an incentivized, anonymous survey. Outcomes were measured via multiple-choice and Likert-type scales, including (1) confidence and comfort with screening and making referrals, (2) current screening and referral activities, (3) awareness of resources, (4) willingness to implement SDoH services, and (5) attitudes regarding SDoH services and were analyzed using descriptive statistics, chi-square analyses, and Pearson correlations.</div></div><div><h3>Results</h3><div>The mean age of the 310 survey participants was 45 ± 9.8 years, and 72% identified as female. Notably, 65% reported working in the community setting; 62% and 65%, respectively, reported a lack of knowledge and ability to identify risks; 84% reported lacking confidence in their ability to address social needs; 55% reported not feeling equipped to use available resources; and 30% indicated currently screening for SDoH at their practice site. Pharmacists identified lack of time (72%) as the most common barrier to screening. Respondents identified lack of resources (65%), personnel (49%), and confidence (32%) and uncertainty of how to link patients to available resources (34%) as other barriers. Most respondents (56%) felt pharmacists could make a positive impact on social risks.</div></div><div><h3>Conclusion</h3><div>Pharmacists reported lack of knowledge, comfort, and experience screening for social risks and barriers to screening for and addressing identified needs. Responses suggest a need for additional training and evaluation of strategies to decrease barriers to SDoH screening and management.</div></div>","PeriodicalId":100737,"journal":{"name":"JAPhA Practice Innovations","volume":"2 2","pages":"Article 100033"},"PeriodicalIF":0.0,"publicationDate":"2025-03-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143705903","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Stronger together: a community case study highlighting the benefits of pharmacy and community collaborations","authors":"Anusha Ban,&nbsp;Ashish Shrestha,&nbsp;Carissa Van-den Berk Clark,&nbsp;Janice Ballard,&nbsp;Richard Logan Jr.,&nbsp;Tripp Logan Sr.,&nbsp;Anne Francioni,&nbsp;Megan Murray,&nbsp;Elizabeth A. Baker","doi":"10.1016/j.japhpi.2024.100024","DOIUrl":"10.1016/j.japhpi.2024.100024","url":null,"abstract":"<div><h3>Background</h3><div>The pandemic exposed weaknesses in existing social and health care infrastructures, disproportionately affecting health outcomes, particularly within rural communities. Addressing these challenges within rural settings requires innovative interventions.</div></div><div><h3>Objective</h3><div>This study seeks to evaluate the role of an interagency network in increasing vaccine uptake in rural settings.</div></div><div><h3>Methods</h3><div>The Network, a partnership of community-based clinical and social service organizations, including community pharmacists, community health workers, and academic researchers, implemented outreach activities which targeted factors related to access to and acceptance of coronavirus disease-2019 vaccines at the individual, interpersonal, community, and environmental levels. Qualitative methods, including in-depth interviews and content analysis of transcripts from planning and networking meetings, were subjected to narrative analysis to document the effectiveness of this multicomponent intervention.</div></div><div><h3>Results</h3><div>Through different outreach efforts, the Network was able to achieve 84,206 educational touchpoints and administer 14,769 vaccines to individuals in the 16-county project area in southeastern Missouri. Leveraging the influence of community pharmacists and community health workers was found to be effective in overcoming barriers to access, improving vaccine uptake, and addressing social and health inequities. Facilitators for the partnership and the success of its initiatives included trust, capacity building, and enhancing access, while poor communication, and unclear role definition created barriers.</div></div><div><h3>Conclusion</h3><div>Study highlights the benefits of community health workers and community pharmacists working collaboratively to increase vaccine uptake in rural Missouri. Findings provide support for expanding this model for future health initiatives.</div></div>","PeriodicalId":100737,"journal":{"name":"JAPhA Practice Innovations","volume":"2 1","pages":"Article 100024"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143177255","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Improvement in HIV screening follow-up rates with emergency medicine pharmacist counseling and dispensing of postexposure prophylaxis for sexual assault patients","authors":"Kevin A. Kaucher,&nbsp;Nicole M. Acquisto,&nbsp;Eric Gilliam,&nbsp;Katharine Lowrey,&nbsp;Michelle Metz,&nbsp;Jennie Buchanan","doi":"10.1016/j.japhpi.2024.100025","DOIUrl":"10.1016/j.japhpi.2024.100025","url":null,"abstract":"<div><h3>Background</h3><div>Patients presenting to the emergency department (ED) within 72 hours of sexual assault should be offered HIV nonoccupational postexposure prophylaxis (nPEP) and directed to follow-up care. However, low rates of follow-up HIV screening and medication adherence have been consistently found. Strategies to improve these rates have not been universally established.</div></div><div><h3>Objectives</h3><div>To describe improvement in follow-up HIV screening and nPEP medication adherence following emergency medicine (EM) pharmacist involvement in counseling and nPEP dispensing.</div></div><div><h3>Methods</h3><div>This single-center, retrospective, pre-/postimplementation analysis compared rates of sexual assault patient follow-up HIV screening prior to and following initiation of EM pharmacist counseling and dispensing of a 28-day supply of nPEP between January 1, 2016 to December 31, 2016 (preintervention) and January 1, 2017 to December 31, 2019 (postintervention). A telephone survey was administered to identify nPEP medication adherence and related adverse drug event (ADE) rates between August 1, 2018 through August 31, 2019 in the postintervention group.</div></div><div><h3>Results</h3><div>The chart review included 369 unique sexual assault patients prescribed nPEP. The number of patients completing at least one follow-up HIV screening and number of screening occurrences within 6 months of nPEP initiation increased from 3 (3.3%) to 12 (14%) and 4 (1.4%) to 23 (8.9%) from 2016 (preintervention) to 2019 (postintervention), respectively, both <em>P</em> &lt; 0.01. Twenty of 85 patients completed a telephone survey during the postimplementation period. Eight patients (40%) reported completing the 28-day nPEP regimen, and 14 patients (70%) experienced an nPEP-related ADE.</div></div><div><h3>Conclusions</h3><div>EM pharmacist counseling and providing a free complete 28-day supply of nPEP contributed to improved rates of follow-up HIV screening for sexual assault patients after ED discharge.</div></div>","PeriodicalId":100737,"journal":{"name":"JAPhA Practice Innovations","volume":"2 1","pages":"Article 100025"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143177252","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Development of a curriculum to improve PrEP awareness and counseling at a national pharmacy chain","authors":"Charles M. Burns,&nbsp;Stephanie S. Sperry,&nbsp;Sarah E. Janek,&nbsp;Dan V. Blalock,&nbsp;Sandra Woolson,&nbsp;Pam Gentry,&nbsp;Megan Oakes,&nbsp;Kenric B. Ware,&nbsp;Michael V. Relf,&nbsp;Nwora Lance Okeke,&nbsp;Noelle Esquire,&nbsp;Tariq Omarshah,&nbsp;Miriam C. Fenton,&nbsp;Jennifer Ribbron,&nbsp;Hayden B. Bosworth","doi":"10.1016/j.japhpi.2024.100023","DOIUrl":"10.1016/j.japhpi.2024.100023","url":null,"abstract":"<div><h3>Background</h3><div>Human immunodeficiency virus (HIV) pre-exposure prophylaxis (PrEP) is underutilized nationally. Community pharmacies are an ideal location to provide PrEP services because they are easily accessible and trusted by patients.</div></div><div><h3>Objective</h3><div>This study aimed to design and implement an educational curriculum on PrEP care for pharmacists.</div></div><div><h3>Methods</h3><div>We developed a 10-module (5 core and 5 advanced) curriculum that could be accessed as needed to fit within the time constraints of pharmacy personnel. Each module ranged from 8 to 22 minutes in length for a total of 125 minutes. The materials were created by an interdisciplinary team of 5 clinical PrEP experts, 1 pharmacist, 5 implementation scientists, 2 members of the Elton John AIDS Foundation, and 3 members of the Walmart executive pharmacy leadership team. The modules were distributed via an online learning platform on December 1, 2022, to Walmart pharmacies located in the United States. All members of the Walmart pharmacy health care team were eligible to participate in the frcurriculum. Initial invites were sent to 15,477 and 15,461 pharmacists for the core and advanced modules, respectively. Outcomes of interest included the number of participants accessing the curriculum and pre- and postcurriculum learning assessments. Data collection occurred from January 26, 2023, to September 1, 2024.</div></div><div><h3>Results</h3><div>A total of 3257 individuals registered for the core curriculum with 2598 completing the core, whereas 1725 individuals registered for the advanced topics with 1574 completing the advanced. Most participants were pharmacists and located in the southern United States. Cohen’s d effect sizes for change in the pre- and postcurriculum in the core modules ranged from −0.02 to 1.03.</div></div><div><h3>Conclusions</h3><div>We successfully created and implemented a pharmacist-centered PrEP educational curriculum within Walmart pharmacies. By increasing PrEP awareness and knowledge among pharmacists, we aimed to increase pharmacist-led PrEP counseling to communities in need of HIV prevention services and contribute toward ending the HIV epidemic in the United States.</div></div>","PeriodicalId":100737,"journal":{"name":"JAPhA Practice Innovations","volume":"2 1","pages":"Article 100023"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143177254","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Implementation of a collaborative practice agreement for depression and anxiety in the primary care setting","authors":"Riley K. Carroll,&nbsp;Lindsey C. Lee,&nbsp;Christopher J. Chiu,&nbsp;Cory P. Coffey","doi":"10.1016/j.japhpi.2024.100021","DOIUrl":"10.1016/j.japhpi.2024.100021","url":null,"abstract":"<div><h3>Background</h3><div>There is a lack of appropriate access to mental health care in the United States, particularly in the underserved community. Data show that individuals living below the poverty level are 2.5 times more likely to develop depression and similar trends have been reported for anxiety. However, socioeconomic status and these conditions are not mutually exclusive and occur throughout the general population. To expand patient access, a collaborative practice agreement (CPA) for major depressive disorder (MDD) and generalized anxiety disorder (GAD) was developed and implemented within a network of primary care clinics.</div></div><div><h3>Objectives</h3><div>This study aimed to (1) describe the development of a pharmacist-led CPA for MDD and GAD within an outpatient primary care clinic and (2) describe the growth of the depression and anxiety CPA service after implementation.</div></div><div><h3>Methods</h3><div>This intervention was completed at a network of 7 primary care clinics associated with a large academic medical center in Columbus, Ohio. A CPA for MDD and GAD was created and implemented in November 2021. An electronic health record–generated report was used to identify patients for which a referral to pharmacy for MDD or GAD was placed between November 1, 2021, and March 1, 2023. A retrospective chart review was used to collect information to describe the growth of the service. Data were analyzed using descriptive statistics.</div></div><div><h3>Results</h3><div>A total of 308 patients were appropriately referred to the pharmacist-led service for MDD and GAD between November 1, 2021, and March 1, 2023. Of the patients who established care with the pharmacist, 35% (54 of 155) experienced improvement in symptoms and 29% (45 of 155) achieved remission.</div></div><div><h3>Conclusion</h3><div>The implementation of a pharmacist-led CPA for MDD and GAD in a primary care setting improved patient access to pharmacotherapy management for depression and anxiety.</div></div>","PeriodicalId":100737,"journal":{"name":"JAPhA Practice Innovations","volume":"2 1","pages":"Article 100021"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143395716","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Before you click submit: Double check your manuscript","authors":"Kimberly M. Kelly,&nbsp;Spencer Harpe,&nbsp;Kenneth C. Hohmeier","doi":"10.1016/j.japhpi.2024.100022","DOIUrl":"10.1016/j.japhpi.2024.100022","url":null,"abstract":"<div><div>Numerous books and articles have been published about scientific writing. Largely missing in this discussion is the mechanics of reviewing one’s own writing and its suitability for a journal—that critical step before authors click the “submit” button in their online manuscript submission. Although individual authors may have developed their own prescriptive checklists for self-editing, such tools have not been widely available for broad distribution. We intend to address this need. To avoid the potential pitfalls of scientific writing, we present a checklist to help writers in the critical step between drafting the manuscript and sending the manuscript to a journal.</div></div>","PeriodicalId":100737,"journal":{"name":"JAPhA Practice Innovations","volume":"2 1","pages":"Article 100022"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143177253","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Pharmacist intervention to improve controlled substance dispensing and use practices in Texas: A pilot study","authors":"J. Douglas Thornton,&nbsp;Nina Z.Y. Smith,&nbsp;Olajumoke A. Olateju,&nbsp;Matthew A. Wanat,&nbsp;Alia M. Altaie,&nbsp;Tyler J. Varisco","doi":"10.1016/j.japhpi.2024.100019","DOIUrl":"10.1016/j.japhpi.2024.100019","url":null,"abstract":"<div><h3>Background</h3><div>Pharmacists play an important role in preventing and addressing opioid-related harm; as such, efforts to encourage and improve their participation are valuable. Face-to-face peer-pharmacist-delivered academic detailing targeted at community pharmacists may serve a role to support best practices in dispensing controlled substances (CS).</div></div><div><h3>Objectives</h3><div>The objectives of the project were to (1) develop and pilot an academic detailing intervention, (2) determine the feasibility of delivering the intervention, and (3) determine which knowledge and practice should be emphasized during the education. This information would drive refinements to the project before it was expanded.</div></div><div><h3>Methods</h3><div>Educational content and materials were developed based on previous research on dispensing practices and on delivering academic detailing. A pharmacist trainer visited community pharmacists to deliver education and to collect data about knowledge and practices surrounding CS dispensing. The community pharmacists were also offered drug disposal products for distribution to patients.</div></div><div><h3>Results</h3><div>A total of 53 community pharmacies in Fort Bend County, TX, were identified as potential targets for the intervention. Seven were determined to be ineligible and the pharmacists in 33 pharmacies consented to participation. Before the intervention, 60.6% of the participating pharmacists reported feeling uncomfortable filling CS and disposal of leftover CS was infrequently addressed with patients. Most pharmacies did not use drug disposal systems before intervention and most pharmacies were interested in receiving free drug disposal envelopes through the intervention.</div></div><div><h3>Conclusion</h3><div>An educational intervention was developed and pilot tested. The pilot showed the intervention’s feasibility and suggested which educational content needed to be abridged to accommodate community pharmacists’ busy practices. Plans were made to scale up the intervention to include more peer pharmacists and community pharmacies.</div></div>","PeriodicalId":100737,"journal":{"name":"JAPhA Practice Innovations","volume":"1 4","pages":"Article 100019"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142427958","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Impact of pharmacist-led transitions of care model on length of hospital stay and 30-day readmission rates at a quaternary care hospital: A pilot study","authors":"Joanna Saleh,&nbsp;Wasim S. El Nekidy,&nbsp;Mohamed Hisham,&nbsp;Hazem Elrefaei,&nbsp;Emna Abidi,&nbsp;Malak AlTakruri,&nbsp;Oussama Kalagieh,&nbsp;Salma Alzaabi,&nbsp;Bassam Atallah,&nbsp;Omar Chehab,&nbsp;Rami Ismail,&nbsp;Saad Sultan","doi":"10.1016/j.japhpi.2024.100015","DOIUrl":"10.1016/j.japhpi.2024.100015","url":null,"abstract":"<div><h3>Background</h3><p>Data about the impact of pharmacist-led transitions of care (TOC) approach are not well established.</p></div><div><h3>Objectives</h3><p>The objective of this pilot study was to evaluate the impact of pharmacist-led TOC enhanced workflow on the length of hospital stay (LOS) and the 30-day hospital readmission rates (HRRs).</p></div><div><h3>Methods</h3><p>This is a quality improvement pilot project conducted at a quaternary care hospital in the United Arab Emirates over 6 weeks on a medical floor and 4 weeks on a cardiac floor. TOC was defined as admission medication reconciliation (AMR) and discharge medication reconciliation (DMR).</p></div><div><h3>Results</h3><p>The median LOS was statistically significantly lower in patients who received AMR on the medical floor (4 days [3-8]) than those who did not (7 days [4-20]) (<em>P</em> &lt; 0.001). The median LOS on the cardiac floor was not statistically significantly affected—3 (1.75-8) versus 3 (1-8) (<em>P</em> = 0.736). However, the multivariate linear regression model, adjusting for the number of interventions, indicated that LOS was statistically significantly lower on both floors; AMR was an independent risk factor for reducing the LOS on the medical floor (B = −8.37 [95 CI −11.37 to −5.36], <em>P</em> = .001) and on the cardiac floor (B = −2.76 [95% CI −5.23 to −0.28], <em>P</em> = 0.029). The 30-day HRR was not different on the medical floor but was numerically lower on the cardiac floor in patients who received DMR alone (12.9%) than in those who did not (17.2%) (<em>P</em> = 0.476). However, the multivariate logistic regression analysis, adjusting for number of interventions, indicated that the pharmacist-led AMR and DMR combined were numerically associated with lower rates of 30-day HRR with respective odds ratios of 0.64 (95% CI 0.3–1.38) and 0.83 (95% CI 0.4–1.9) (<em>P</em> = 0.83) on the medical floor and of 0.96 (95% CI 0.3–2.6) and 0.7 (95% CI 0.3–1.8) (<em>P</em> = 0.28) on the cardiac floor. In addition, the impact of the described pharmacist-led TOC approach on health care costs at the hospital was quantifiable and reflected a median medications utilization cost of $1142.95 (639.69-2444.88) when TOC is performed versus $1371.54 (402.92-4277.39) without TOC (<em>P</em> &lt; 0.001) on the medical floor and of $4728.98 (2436.66-6846.34) versus $5252.79 (3907.63-7784.57) (<em>P</em> &lt; 0.001) on the cardiac floor throughout the study time period.</p></div><div><h3>Conclusion</h3><p>Pharmacist-led TOC interventions, specifically AMR, significantly reduced the LOS on the medical and the cardiac floors, whereas both AMR and DMR represented promising predictors of decreased 30-day HRR on the studied floors. Furthermore, the TOC interventions were generally associated with a statistically significant financial impact on both studied floors.</p></div>","PeriodicalId":100737,"journal":{"name":"JAPhA Practice Innovations","volume":"1 4","pages":"Article 100015"},"PeriodicalIF":0.0,"publicationDate":"2024-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2949969024000083/pdfft?md5=2c847fbe9649dca2c6a23f0fd97e8592&pid=1-s2.0-S2949969024000083-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142150158","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Implementing a meningococcal B vaccination multimedia educational campaign for university students","authors":"Lucas A. Berenbrok,&nbsp;Kim C. Coley,&nbsp;Oscar Herrera-Restrepo,&nbsp;Misty Anderson,&nbsp;Cate Polacek,&nbsp;Douglas Landsittel","doi":"10.1016/j.japhpi.2024.100016","DOIUrl":"10.1016/j.japhpi.2024.100016","url":null,"abstract":"<div><h3>Background</h3><p>Meningococcal serogroup B (MenB) is the leading cause of potentially fatal meningococcal disease among U.S. older adolescents and young adults; college students are at increased risk. Although the Advisory Committee on Immunization Practices recommends that healthy 16- to 23-year-olds may be vaccinated against MenB, MenB vaccination coverage is low.</p></div><div><h3>Objective</h3><p>This study investigated the impact of a comprehensive multimedia MenB vaccine educational campaign on 2-dose MenB vaccine series initiation among college students.</p></div><div><h3>Methods</h3><p>We implemented a 6-week-long (October 11, 2021-November 19, 2021) educational intervention via a prospective trial on a university campus (the intervention campus), including video broadcasting, student-led campus programming, and printed materials. The control campus was a different university in the same urban setting.</p></div><div><h3>Results</h3><p>During baseline period 1 (August 26, 2019-November 15, 2019), 2 students on the intervention campus and 3 students on the control campus initiated the MenB vaccination series; 1 student initiated the series on the intervention campus during baseline period 2 (August 27, 2021-October 8, 2021). At least 83 students were exposed to the campaign during the intervention period (October 11, 2021-November 19, 2021). No students initiated the MenB vaccination series during the intervention period, although 1 student completed the vaccination series.</p></div><div><h3>Conclusion</h3><p>The campaign did not influence MenB vaccination initiation on the university campus.</p></div>","PeriodicalId":100737,"journal":{"name":"JAPhA Practice Innovations","volume":"1 4","pages":"Article 100016"},"PeriodicalIF":0.0,"publicationDate":"2024-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2949969024000095/pdfft?md5=22045088a5ed8e60b9c9c621da2ef62e&pid=1-s2.0-S2949969024000095-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142135126","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}